Show simple item record

dc.contributor.authorChallapalli, A.
dc.contributor.authorWatkins, S.
dc.contributor.authorCogill, G.
dc.contributor.authorStewart, G.
dc.contributor.authorEllis, S.
dc.contributor.authorSykes, A.
dc.contributor.authorNobes, J.
dc.contributor.authorYip, K.
dc.contributor.authorBarthakur, U.
dc.contributor.authorBoard, R.
dc.contributor.authorGadve, A.
dc.contributor.authorO'Toole, L.
dc.contributor.authorKent, C.
dc.contributor.authorMackenzie, J.
dc.contributor.authorPapa, S.
dc.contributor.authorFusi, A.
dc.contributor.authorFife, K.
dc.date.accessioned2022-04-28T13:57:49Z
dc.date.available2022-04-28T13:57:49Z
dc.date.issued2022en
dc.identifier.citationChallapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, et al. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022.en
dc.identifier.pmid35298050en
dc.identifier.doi10.1111/jdv.18082en
dc.identifier.urihttp://hdl.handle.net/10541/625189
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1111/jdv.18082en
dc.titleCemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Schemeen
dc.typeOtheren
dc.identifier.journalJournal of the European Academy of Dermatology and Venereologyen
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record